British biotech responds to allegations.
McCullagh
K
K
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001709:Biotechnology / Q000331:legislation & jurisprudence; D017326:Clinical Trials, Phase III as Topic; D006801:Humans; D008666:Metalloendopeptidases / Q000037:antagonists & inhibitors; D010195:Pancreatitis / Q000188:drug therapy; D010649:Phenylalanine / Q000031:analogs & derivatives / Q000627:therapeutic use; D013876:Thiophenes / Q000627:therapeutic use; D006113:United Kingdom
D000970:Antineoplastic Agents; D013876:Thiophenes; D010649:Phenylalanine; C080985:batimastat; D008666:Metalloendopeptidases